Central nervous system manifestations of COVID-19: A systematic review

Ali A Asadi-Pooya, Leila Simani, Ali A Asadi-Pooya, Leila Simani

Abstract

Objective: In this systematic review, we will discuss the evidence on the occurrence of central nervous system (CNS) involvement and neurological manifestations in patients with COVID-19.

Methods: MEDLINE (accessed from PubMed) and Scopus from December 01, 2019 to March 26, 2020 were systematically searched for related published articles. In both electronic databases, the following search strategy was implemented and these key words (in the title/abstract) were used: "COVID 19" OR "coronavirus" AND "brain" OR "CNS" OR "neurologic".

Results: Through the search strategy, we could identify two articles about neurological involvement by COVID-19. One of these publications was a narrative review and the other one was a viewpoint. However, the authors scanned the reference lists of the included studies and could identify multiple references. One study, specifically investigated the neurological manifestations of COVID-19 and could document CNS manifestations in 25% of the patients. Most of the studies investigated the manifestations of COVID-19 in general.

Conclusion: While neurological manifestations of COVID-19 have not been studied appropriately, it is highly likely that some of these patients, particularly those who suffer from a severe illness, have CNS involvement and neurological manifestations. Precise and targeted documentation of neurological symptoms, detailed clinical, neurological, and electrophysiological investigations of the patients, attempts to isolate SARS-CoV-2 from cerebrospinal fluid, and autopsies of the COVID-19 victims may clarify the role played by this virus in causing neurological manifestations.

Keywords: CNS; COVID-19; Coronavirus; Neurological; Seizure.

Conflict of interest statement

Disclosures Ali A. Asadi-Pooya, M.D.: Honoraria from Cobel Daruo, RaymandRad and Tekaje; Royalty: Oxford University Press (Book publication). Leila Simani, PhD.: none.

Copyright © 2020 Elsevier B.V. All rights reserved.

Figures

Fig. 1
Fig. 1
Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flow diagram of the study.

References

    1. Rothan H.A., Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 2020;102433
    1. Desforges M., Le Coupanec A., Dubeau P. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2020;12:14.
    1. Bohmwald K., Galvez N., Ríos M., Kalergis A.M. Neurologic alterations due to respiratory virus infections. Front. Cell. Neurosci. 2018;12:386.
    1. Hutton B., Salanti G., Caldwell D.M. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann. Intern. Med. 2015;162:777–784.
    1. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 2009;151:264–269.
    1. Gronseth G.S.C.J., Gloss D., Merillat S., Dittman J., Armstrong M.J., on behalf of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology . 2017 ed. The American Academy of Neurology; Minneapolis, MN: 2017. Clinical Practice Guideline Process Manual; p. 2017.
    1. Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J. Med. Virol. 2020 Feb 27 doi: 10.1002/jmv.25728. In press.
    1. Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020;11(7):995–998.
    1. Mao L., Wang M., Chen S. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a Retrospective Case Series Study.
    1. Li Y., Wang M., Zhou Y. Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study. 2020.
    1. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
    1. Yang X., Yu Y., Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020 Feb 24 doi: 10.1016/S2213-2600(20)30079-5. pii: S2213-2600(20)30079-5. In press.
    1. Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020 Feb 7 doi: 10.1001/jama.2020.1585. In press.
    1. Chen N., Zhou M., Dong X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
    1. Hung E.C., Chim S.S., Chan P.K. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin. Chem. 2003;49:2108–2109.
    1. Lau K.-K., Yu W.-C., Chu C.-M., Lau S.-T., Sheng B., Yuen K.-Y. Possible central nervous system infection by SARS coronavirus. Emerg. Infect. Dis. 2004;10:342.
    1. Li Y., Li H., Fan R. Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology. 2016;59:163–169.
    1. Saad M., Omrani A.S., Baig K. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int. J. Infect. Dis. 2014;29:301–306.
    1. Miró J.M., de Terán F.D., Singer P.A., Prior M.A.-A. Emergency electroencephalogram: Usefulness in the diagnosis of nonconvulsive status epilepticus by the on-call neurologist. Neurología (English Edn) 2018;33:71–77.
    1. Leitinger M., Beniczky S., Rohracher A. Salzburg consensus criteria for non-convulsive status epilepticus–approach to clinical application. Epilepsy Behav. 2015;49:158–163.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera